{
    "eid": "2-s2.0-85165918680",
    "title": "Using a discrete choice experiment to elicit patients\u2019 preferences and willingness-to-pay for knee osteoarthritis treatments in Thailand",
    "cover-date": "2023-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Parnnaphat Luksameesate",
        "Aree Tanavalee",
        "Surachat Ngorsuraches",
        "Suthira Taychakhoonavudh"
    ],
    "citedby-count": 0,
    "ref-count": 53,
    "ref-list": [
        "An insight into rheumatology in Thailand",
        "The epidemiology of osteoarthritis in Asia",
        "Knee osteoarthritis in adult and older Thais living in rural and urban areas: A comparative study",
        "Cardiovascular risk associated with NSAIDs and COX-2 inhibitors",
        "Health Technology Assessment (HTA) evidence, regulatory classification and reimbursement of medicine: The case of glucosamine",
        "Glucosamine therapy for treating osteoarthritis",
        "Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys",
        "Crystalline glucosamine sulfate in the management of knee osteoarthritis: Efficacy, safety, and pharmacokinetic properties",
        "Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: A meta-analysis of placebo-controlled trials",
        "A review of glucosamine for knee osteoarthritis: Why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes",
        "Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: Results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials",
        "Glucosamine sulphate in the treatment of knee osteoarthritis: Cost-effectiveness comparison with paracetamol",
        "The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: A systematic review and economic evaluation",
        "Drug reimbursement decision-making in Thailand, China, and South Korea",
        "Revisit roles of HTA on drug policy in universal health coverage in Thailand: Where are we? And what is next?",
        "Cost-effectiveness analysis of glucosamine sulphate for the treatment of osteoarthritis in Thailand",
        "An economic evaluation of knee osteoarthritis treatments in Thailand",
        "Reasons for nonadherence",
        "Treatment options in knee osteoarthritis: The patient's perspective",
        "Patient preference and willingness to pay for knee osteoarthritis treatments",
        "Patient preferences for adherence to treatment for osteoarthritis: The Medication Decisions in Osteoarthritis Study (MEDOS)",
        "Systematic review of studies using conjoint analysis techniques to investigate patients\u2019 preferences regarding osteoarthritis treatment",
        "Developing attributes for discrete choice experiments in health: A systematic literature review and case study of alcohol misuse interventions",
        "Celecoxib versus diclofenac in the management of osteoarthritis of the knee: A placebo-controlled, randomised, double-blind comparison",
        "Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study",
        "Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: A randomized trial",
        "Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials",
        "Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis",
        "Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies",
        "Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator",
        "A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis",
        "Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis",
        "Outcomes of total hip and knee replacement: Preoperative functional status predicts outcomes at six months after surgery",
        "Glucosamine long-term treatment and the progression of knee osteoarthritis: Systematic review of randomized controlled trials",
        "The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial",
        "NSAID use and progression of chronic kidney disease",
        "Role of nonsteroidal antiinflammatory drugs in the association between osteoarthritis and cardiovascular diseases: A longitudinal study",
        "Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies",
        "Osteoarthritis",
        "Sample size requirements for discrete-choice experiments in healthcare: A practical guide",
        "Mixed logit estimation of willingness to pay distributions: a comparison of models in preference and WTP space using data from a health-related choice experiment",
        "A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis",
        "Patients' preferences for characteristics associated with treatments for osteoarthritis",
        "Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT",
        "Etoricoxib for arthritis and pain management",
        "Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: A randomised comparison"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Auburn",
            "@id": "60001085",
            "affilname": "Harrison School of Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001085",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}